BACKGROUND: Streptococcus pneumoniae is the leading cause of vaccine-preventable death in children <5 years of age globally. We determined incidence rates of invasive pneumococcal disease (IPD), clinical and chest X-ray-confirmed pneumonia (CXR+Pn), S. pneumoniae serotype distribution, and antimicrobial susceptibility in children in Goiânia, Brazil. METHODS: Prospective, population-based surveillance was conducted from May 2007 to May 2009 in children 28 days to <36 months of age presenting to all 33 pediatric healthcare services (outpatient departments, emergency rooms, hospitals) in Goiânia. Eligibility criteria were temperature ≥39.0 °C in the previous 24h and/or clinical suspicion of pneumonia or IPD. RESULTS: 14,509 subjects were enrolled. Median age was 14.0 months. S. pneumoniae was detected in 64 samples from 62 subjects: 58 (90.6%) blood; 4 (6.3%) cerebrospinal fluid; and 2 (3.1%) pleural fluid. Incidence rate of IPD (culture- and polymerase chain reaction-positive) for all children aged 28 days to <36 months was 57.5/100,000; overall incidence for culture-positive only was 54.9/100,000. Age stratification of culture-positive-only subjects found the highest rates were, 114.6/100,000 and 69.8/100,000, respectively, for the 6 months to <12 months and 12 months to <24 months age groups. The overall incidence of invasive pneumonia and pneumococcal meningitis was 37.2/100,000 and 5.3/100,000, respectively. The most common IPD serotypes were 14 (45.0%), 6B (13.3%), 18C (6.7%), and 23F (5.0%). Eight isolates (13.3%) were penicillin nonsusceptible. The cumulative percentages of serotypes included in 7-valent, 10-valent, and 13-valent pneumococcal conjugate vaccines were 78.3%, 80.0%, and 88.3%, respectively. The overall incidence of clinical pneumonia and CXR+Pn was, 9598/100,000 and 3428/100,000, respectively. CXR+Pn rates for hospitalized and non-hospitalized subjects were 1751/100,000 and 1677/100,000, respectively. CONCLUSIONS: The burden of IPD and pneumonia is considerable in children in a large Brazilian city, and is seen in hospitalized as well as ambulatory subjects. Vaccination with pneumococcal conjugate vaccines has the potential to decrease this burden. Copyright Â
BACKGROUND:Streptococcus pneumoniae is the leading cause of vaccine-preventable death in children <5 years of age globally. We determined incidence rates of invasive pneumococcal disease (IPD), clinical and chest X-ray-confirmed pneumonia (CXR+Pn), S. pneumoniae serotype distribution, and antimicrobial susceptibility in children in Goiânia, Brazil. METHODS: Prospective, population-based surveillance was conducted from May 2007 to May 2009 in children 28 days to <36 months of age presenting to all 33 pediatric healthcare services (outpatient departments, emergency rooms, hospitals) in Goiânia. Eligibility criteria were temperature ≥39.0 °C in the previous 24h and/or clinical suspicion of pneumonia or IPD. RESULTS: 14,509 subjects were enrolled. Median age was 14.0 months. S. pneumoniae was detected in 64 samples from 62 subjects: 58 (90.6%) blood; 4 (6.3%) cerebrospinal fluid; and 2 (3.1%) pleural fluid. Incidence rate of IPD (culture- and polymerase chain reaction-positive) for all children aged 28 days to <36 months was 57.5/100,000; overall incidence for culture-positive only was 54.9/100,000. Age stratification of culture-positive-only subjects found the highest rates were, 114.6/100,000 and 69.8/100,000, respectively, for the 6 months to <12 months and 12 months to <24 months age groups. The overall incidence of invasive pneumonia and pneumococcal meningitis was 37.2/100,000 and 5.3/100,000, respectively. The most common IPD serotypes were 14 (45.0%), 6B (13.3%), 18C (6.7%), and 23F (5.0%). Eight isolates (13.3%) were penicillin nonsusceptible. The cumulative percentages of serotypes included in 7-valent, 10-valent, and 13-valent pneumococcal conjugate vaccines were 78.3%, 80.0%, and 88.3%, respectively. The overall incidence of clinical pneumonia and CXR+Pn was, 9598/100,000 and 3428/100,000, respectively. CXR+Pn rates for hospitalized and non-hospitalized subjects were 1751/100,000 and 1677/100,000, respectively. CONCLUSIONS: The burden of IPD and pneumonia is considerable in children in a large Brazilian city, and is seen in hospitalized as well as ambulatory subjects. Vaccination with pneumococcal conjugate vaccines has the potential to decrease this burden. Copyright Â
Authors: Juliana Caierão; Paulina Hawkins; Fernando Hayashi Sant'anna; Gabriela Rosa da Cunha; Pedro Alves d'Azevedo; Lesley McGee; Cícero Dias Journal: PLoS One Date: 2014-10-30 Impact factor: 3.240
Authors: S Sgambatti; R Minamisava; E T Afonso; C M Toscano; A L Bierrenbach; A L Andrade Journal: Epidemiol Infect Date: 2014-04-23 Impact factor: 4.434
Authors: Fabricia Oliveira Saraiva; Ruth Minamisava; Maria Aparecida da Silva Vieira; Ana Luiza Bierrenbach; Ana Lucia Andrade Journal: PLoS One Date: 2015-06-10 Impact factor: 3.240
Authors: Jennifer R Verani; John McCracken; Wences Arvelo; Alejandra Estevez; Maria Renee Lopez; Lissette Reyes; Juan Carlos Moir; Chris Bernart; Fabiola Moscoso; Jennifer Gray; Sonja J Olsen; Kim A Lindblade Journal: PLoS One Date: 2013-12-31 Impact factor: 3.240
Authors: Janepsy Diaz; Solana Terrazas; Ana L Bierrenbach; Cristiana M Toscano; Gizelton P Alencar; Andrés Alvarez; Maria T Valenzuela; Jon Andrus; Roberto del Aguila; Juan C Hormazábal; Pamela Araya; Paola Pidal; Cuauhtemoc R Matus; Lucia H de Oliveira Journal: PLoS One Date: 2016-04-08 Impact factor: 3.240
Authors: Natália S Costa; Tatiana C A Pinto; Vânia L C Merquior; Luciana F S Castro; Filomena S P da Rocha; Jaqueline M Morais; José M Peralta; Lúcia M Teixeira Journal: PLoS One Date: 2016-07-08 Impact factor: 3.240
Authors: Milena Soares dos Santos; Jailton Azevedo; Ana Paula de Oliveria Menezes; Soraia Machado Cordeiro; Eliane Cunegundes Escobar; Josilene Borges Lima; Leila Carvalho Campos; Maria da Glória S Carvalho; Mitermayer G Reis; Albert I Ko; Joice Neves Reis Journal: BMC Infect Dis Date: 2015-07-30 Impact factor: 3.090